Recall: Brimonidine
Mar. 2023Pharmacy Updates
Apotex Corp. is voluntarily recalling six lots of Brimonidine Tartrate Ophthalmic Solution, 0.15%. The drug is used to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. This recall is due to cracks that have developed in some of the Brimonidine tartrate ophthalmic solution bottles’ caps. Read the full text of the Brimonidine recall.
Recent Announcements
CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care
Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.Aug. 2026Education/Webinars
CME Webinar: Getting it Right from the Start: Identifying Patient Advanced Care Directives
Please join us for a live, CME-accredited webinar on Thursday, Oct. 15, 2026 that will educate providers on identifying advanced directives and surrogate decision makers on admission.Aug. 2026Education/Webinars
Watch for a chance to rate your experience with UPMC Health Plan
Watch for a chance to rate your experience with UPMC Health Plan. You may be randomly selected to participate in a 2026 Press Ganey provider satisfaction survey that will begin this month.Aug. 2026Important Notices